Definition
Joel N. Blankson is an American virologist and HIV researcher known for his contributions to the study of HIV latency, viral reservoirs, and antiretroviral therapy.
Overview
Blankson holds a faculty position at the University of Washington School of Medicine, where he serves in the Department of Laboratory Medicine and the Division of Infectious Diseases. His research focuses on the mechanisms by which HIV persists in infected individuals despite long‑term antiretroviral treatment, with particular emphasis on the characterization of latent viral reservoirs and strategies for viral eradication. Blankson has authored or co‑authored numerous peer‑reviewed articles in journals such as Nature Medicine, Journal of Clinical Investigation, and AIDS, and he frequently collaborates with clinical trial investigators to translate basic findings into therapeutic approaches.
Etymology/Origin
The surname “Blankson” is of English origin, historically meaning “son of Blank,” where “Blank” is derived from a medieval personal name or nickname. The middle initial “N.” likely represents a given middle name, though publicly available sources do not specify its meaning.
Characteristics
- Research Expertise: HIV‑1 molecular virology, latency reversal agents, quantitative viral outgrowth assays, and immunologic correlates of viral control.
- Methodological Approach: Employs a combination of ex‑vivo cell culture systems, high‑throughput sequencing, and flow cytometry to quantify and characterize replication‑competent HIV.
- Academic Contributions: Over 100 scientific publications; cited extensively in the fields of virology and immunology.
- Professional Service: Serves on editorial boards for virology journals and is a member of societies such as the International AIDS Society and the American Society for Virology.
- Awards and Honors: Recognized with research funding from the National Institutes of Health (NIH) and has received institutional accolades for mentorship and scientific excellence.
Related Topics
- HIV latency and reservoirs
- Antiretroviral therapy (ART)
- Viral outgrowth assays
- Cure research for HIV/AIDS
- Immunology of chronic viral infections
Note: Information presented reflects publicly available academic and professional records up to 2026 and does not include private or undisclosed details.